VietNam News Agency
16/07/2025 - 16:25’ (GMT +7)
Tiếng Việt
English
Français
Español
中文
Русский
|
Culture
Law
Economy
Education
Environment
Health
Life
Employment
Lifestyle
Politics
Science and technology
Society
Security-Defence
Home
Politics
SOCIETY
ECONOMY
Photos
Infographic
Information Service
RSS
Information service
Operating operations
Xembao.vn
Look up information
News
Photos
Vietnam's homegrown Nanocovax COVID-19 vaccine candidate to be assessed by Indian institute
Photo: Vietnamese and Indian delegates at the signing ceremony. VNA Photo: Huy Lê
Photo: Vietnamese Ambassador to India Pham Sanh Chau speaks at the event. VNA Photo: Huy Lê
VNA Photos
Vietnam's homegrown Nanocovax COVID-19 vaccine candidate to be assessed by Indian institute
09/23/2021 22:55
|
TTXVN
|
The Translational Health Science & Technology Institute (THSTI) will evaluate immunogenicity of the Made-in-Vietnam Nanocovax COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam. A memorandum of understanding to this effect was signed at a ceremony held in Faridabad city of India’s Haryana state on September 23. Under the agreement, Nanogen will send cell samples of volunteers participating in the third trial phase of Nanocovax to the THSTI for assessment. VNA Photo: Huy Lê
Vietnam's homegrown Nanocovax COVID-19 vaccine candidate to be assessed by Indian institute
The Translational Health Science & Technology Institute (THSTI) will evaluate immunogenicity of the Made-in-Vietnam Nanocovax COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam. A memorandum of understanding to this effect was signed at a ceremony held in Faridabad city of India’s Haryana state on September 23. Under the agreement, Nanogen will send cell samples of volunteers participating in the third trial phase of Nanocovax to the THSTI for assessment. VNA Photo: Huy Lê
Vietnam's homegrown Nanocovax COVID-19 vaccine candidate to be assessed
The Translational Health Science & Technology Institute (THSTI) will evaluate immunogenicity of the Made-in-Vietnam Nanocovax COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam. A memorandum of understanding to this effect was signed at a ceremony held in Faridabad city of India’s Haryana state on September 23. Under the agreement, Nanogen will send cell samples of volunteers participating in the third trial phase of Nanocovax to the THSTI for assessment. VNA Photo: Huy Lê
Photos
VNA Photos
Latest news
